Inhibition of nuclear factor-κB enhances the antitumor effect of tumor necrosis factor-α gene therapy for hepatocellular carcinoma in mice

Surgery (United States)

Volumn 154, Issue 3, 2013, Pages 468-478

  Haruki, Koichiro ^a   Shiba, Hiroaki ^a   Fujiwara, Yuki ^a   Furukawa, Kenei ^a   Iwase, Ryota ^a   Uwagawa, Tadashi ^a   Misawa, Takeyuki ^a   Ohashi, Toya ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAFAMSTAT MESILATE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT; VIRAL GENE THERAPY;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; GENETIC THERAPY; GUANIDINES; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883259110     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.05.037     Document Type: Article

References (40)

1. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
2. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
3. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
4. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, and J.F. Blanc Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
5. A. Forner, J.M. Llovet, and J. Bruix Hepatocellular carcinoma Lancet 379 2012 1245 1255
6. L.J. Old Tumor necrosis factor (TNF) Science 230 1985 630 632
7. D.R. Spriggs, M.L. Sherman, H. Michie, K.A. Arthur, K. Imamura, and D. Wilmore Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic study J Natl Cancer Inst 80 1988 1039 1044
8. C.Y. Wang, M.W. Mayo, and A.S. Baldwin Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB Science 274 1996 784 787
9. A.A. Beg, and D. Baltimore An essential role for NF-kappaB in preventing TNF-alpha-induced cell death Science 274 1996 782 784
10. F. Chen, V. Castranova, and X. Shi New insights into the role of nuclear factor-kappaB in cell growth regulation Am J Pathol 159 2001 387 397
11. D.J. Van Antwerp, S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 274 1996 787 789
12. M. Karin, and A. Lin NF-kappaB at the crossroads of life and death Nat Immunol 3 2002 221 227
13. T. Uwagawa, Z. Li, Z. Chang, Q. Xia, B. Peng, and G.M. Sclabas Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death Cancer 109 2007 2142 2153
14. K. Furukawa, T. Iida, H. Shiba, Y. Fujiwara, T. Uwagawa, and Y. Shimada Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse model Oncol Rep 24 2010 843 850
15. K. Haruki, H. Shiba, Y. Fujiwara, K. Furukawa, R. Iwase, and T. Uwagawa Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice Dig Dis Sci 58 2013 123 131
16. K. Furukawa, T. Ohashi, K. Haruki, Y. Fujiwara, T. Iida, and H. Shiba Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in mice Cancer Lett 306 2011 92 98
17. T. Aoyama, Y. Ino, M. Ozeki, M. Oda, T. Sato, and Y. Koshiyama Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments Jpn J Pharmacol 35 1984 203 227
18. M. Iwaki, Y. Ino, A. Motoyoshi, M. Ozeki, T. Sato, and M. Kurumi Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats Jpn J Pharmacol 41 1986 155 162
19. T. Yoshikawa, M. Murakami, Y. Furukawa, H. Kato, S. Takemura, and M. Kondo Effects of FUT-175, a new synthetic protease inhibitor on endotoxin-induced disseminated intravascular coagulation in rats Haemostasis 13 1983 374 378
20. Y. Ohtake, H. Hirasawa, T. Sugai, S. Oda, H. Shiga, and K. Matsuda Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration Contrib Nephrol 93 1991 215 217
21. S. Muto, M. Imai, and Y. Asano Mechanisms of the hyperkalaemia caused by nafamostat mesilate: effects of its two metabolites on Na+ and K+ transport properties in the rabbit cortical collecting duct Br J Pharmacol 111 1994 173 178
22. Y. Kanegae, G. Lee, Y. Sato, M. Tanaka, M. Nakai, and T. Sakaki Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase Nucleic Acids Res 23 1995 3816 3821
23. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1993 193 199
24. Y. Kanegae, M. Makimura, and I. Saito A simple and efficient method for purification on infectious recombinant adenovirus Jpn J Med Sci Biol 47 1994 157 166
25. J.M. Wilson Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency Mol Genet Metab 96 2009 151 157
26. S. Chen, J. Chen, G. Ma, W. Xi, Q. Xu, and W. Xu Clinical therapeutic effect and biological monitoring of p53 gene in advanced hepatocellular carcinoma Am J Clin Oncol 2011 Jan 6 [Epub ahead of print]
27. B. Sangro, G. Mazzolini, M. Ruiz, J. Ruiz, J. Quiroga, and I. Herrero A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma Cancer Gene Ther 17 2010 837 843
28. H. Shiba, T. Misawa, T. Iida, T. Okamoto, Y. Futagawa, and M. Sakurai Adenovirus vector-mediated gene therapy using iodized oil esters for hepatocellular carcinoma in rats Anticancer Res 28 2008 51 53
29. H. Shiba, T. Okamoto, Y. Futagawa, T. Ohashi, and Y. Eto Efficient and cancer-selective gene transfer to hepatocellular carcinoma in a rat using adenovirus vector with iodized oil esters Cancer Gene Ther 8 2001 713 718
30. S.R. Murugesan, C.R. King, R. Osborn, W.R. Fairweather, E.M. O'Reilly, and M.O. Thornton Combination of human tumor necrosis factor-alpha (hTNF-alpha) gene delivery with gemcitabine is effective in models of pancreatic cancer Cancer Gene Ther 16 2009 841 847
31. B. Yamini, X. Yu, G.Y. Gillespie, D.W. Kufe, and R.R. Weichselbaum Transcriptional Targeting of adenovirally delivered tumor necrosis factor α by temozolomide in experimental glioblastoma Cancer Res 64 2004 6381 6384
32. K.J. Chang, T. Reid, N. Senzer, S. Swisher, H. Pinto, and N. Hanna Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer Gastrointest Endosc 75 2012 1139 1146
33. J.R. Hecht, J.J. Farrell, N. Senzer, J. Nemunaitis, A. Rosemurgy, and T. Chung EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study Gastrointest Endosc 75 2012 332 338
34. J. Li, R. Zheng, J. Li, and Z. Wang Mechanisms of the induction of apoptosis in human hepatoma cells by tumour necrosis factor-alpha Cell Biol Int 25 2001 1213 1219
35. M.K. Tietze, T. Wuestefeld, Y. Paul, L. Zender, C. Trautwein, and M.P. Manns IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas Cancer Gene Ther 7 2000 1315 1323
36. T.J. Li, L.P. Jia, X.L. Gao, and A.L. Huang Gene therapy that inhibits NF-kappaB results in apoptosis of human hepatocarcinoma by recombinant adenovirus World J Gastroenterol 12 2006 5287 5292
37. P.J. Chiao, R. Na, J. Niu, G.M. Sclabas, Q. Dong, and S.A. Curley Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells Cancer 95 2002 1696 1705
38. D.I. Tai, S.L. Tsai, Y.H. Chang, S.N. Huang, T.C. Chen, and K.S. Chang Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma Cancer 89 2000 2274 2281
39. T. Uwagawa, T. Misawa, T. Sakamoto, R. Ito, T. Gocho, and H. Shiba A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer Ann Oncol 20 2009 239 243
40. T. Uwagawa, T. Misawa, N. Tsutsui, R. Ito, T. Gocho, and S. Hirohara Phase II study of gemcitabine in combination with regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer Am J Clin Oncol 36 2013 44 48